Page 87 - IMO-2-3

Innovative Medicines & Omics Synthesis and docking of diorganotin (IV) chelates

dithiocarbamate complexes: Chemistry and biological doi: 10.2174/157340911795677602
activity. Molecules. 2018;23(10):2571.
20. Palafox MA, Tardajos G, Guerrero-Martínez A, et al. FT-IR,
doi: 10.3390/molecules23102571 FT-Raman spectra, density functional computations of the
vibrational spectra and molecular geometry of biomolecule
11. Singh HL, Dhingra N, Bhanuka S. Synthesis, spectral, 5-aminouracil. Chem Phys. 2007;340(1-3):17-31.
antibacterial and QSAR studies of tin and silicon
complexes with Schiff base of amino acids. J Mol Struct. doi: 10.1016/j.chemphys.2006.11.020
2023;1287:135670. 21. Khan MA, Kesharwani MK, Bandyopadhyay T,
doi: 10.1016/j.molstruc.2023.135670 Ganguly B. Remarkable effect of hydroxylamine anion
towards the solvolysis of sarin: A DFT study. J Mol Struct
12. Shah FA, Sirajuddin M, Ali S, Abbas SM, Tahir MN, Theochem. 2010;944(1-3):132-136.
Rizzoli C. Synthesis, spectroscopic characterization, X-ray
structure and biological screenings of organotin (IV) 3-[(3, doi: 10.1016/j.theochem.2009.10.003
5-dichlorophenylamido)] propanoates. Inorg Chim Acta. 22. Vogel AI. A Textbook of Quantitative Inorganic Analysis.
2013;400:159-168. 3 ed. London, UK: The English Language Book Society and
rd
doi: 10.1016/j.ica.2013.12.022 Longman; 1961.

13. Liu J, Lin Y, Liu M, et al. Synthesis, structural characterization 23. Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 03,
and cytotoxic activity of triorganotin 5‐(salicylideneamino) Revision 03. Wallingford CT: Gaussian, Inc.; 2004.
salicylates. Appl Organomet Chem. 2019;33(3):e4715. 24. Hampele IC, D’Arcy A, Dale GE, et al. Structure and function
doi: 10.1002/aoc.4715 of the dihydropteroate synthase from Staphylococcus aureus.
J Mol Biol. 1997;268(1):21-30.
14. Latha A, Elangovan N, Manoj KP, et al. Synthesis, single
crystal (XRD), spectral characterization, computational doi: 10.1006/jmbi.1997.0944
(DFT), quantum chemical modelling and anticancer activity 25. Dennis ML, Lee MD, Harjani JR, et al. 8‐mercaptoguanine
of di (p-bromobenzyl)(dibromo)(1, 10-phenanthroline) derivatives as inhibitors of dihydropteroate synthase. Chem
tin(IV) complex. J Indian Chem Soc. 2022;99(10):100714. Eur J. 2018;24(8):1922-1930.
doi: 10.1016/j.jics.2022.100714 doi: 10.1002/chem.201704730
15. Bhaskar C, Elangovan N, Sowrirajan S, et al. Synthesis, 26. Alexander JA, Chatterjee SS, Hamilton SM, Eltis LD,
XRD, Hirshfeld surface analysis, DFT studies, cytotoxicity Chambers HF, Strynadka NC. Structural and kinetic
and anticancer activity of di(m-chlorobenzyl)(dichloro) analyses of penicillin-binding protein 4 (PBP4)-mediated
(4,7-diphenyl-1,10-phenanthroline) tin(IV) complex. J Mol antibiotic resistance in Staphylococcus aureus. J Biol Chem.
Struct. 2022;1267:133542. 2018;293(51):19854-19865.
doi: 10.1016/j.molstruc.2022.133542 doi: 10.1074/jbc.RA118.004952
16. Sharma A, Dhingra N, Singh HL, Khaturia S, Bhardawaj U. 27. Caveney NA, Caballero G, Voedts H, et al. Structural insight
New complexes of organotin(IV) and organosilicon(IV) into YcbB-mediated beta-lactam resistance in Escherichia
with 2-{(3,4-dimethoxybenzylidene) amino}-benzenethiol: coli. Nat Commun. 2019;10(1):1849.
Synthesis, spectral, theoretical, antibacterial, docking
studies. J Mol Struct. 2022;1261:132812. doi: 10.1038/s41467-019-09507-0
doi: 10.1016/j.molstruc.2022.132812 28. Saqallah FG, Hamed WM, Talib WH, Dianita R, Wahab HA.
Antimicrobial activity and molecular docking screening of
17. Pooyan M, Shariatinia Z, Mohammadpanah F, et al. In vitro bioactive components of Antirrhinum majus (snapdragon)
cytotoxicity evaluation of organotin(IV) complexes derived aerial parts. Heliyon. 2022;8(8):e10391.
from bisphosphoramide ligand: DNA binding and molecular
docking studies. J Mol Liq. 2023;391:123442. doi: 10.1016/j.heliyon.2022.e10391
doi: 10.1016/j.molliq.2023.123442 29. Cochrane SA, Lohans CT. Breaking down the cell wall:
Strategies for antibiotic discovery targeting bacterial
18. Mansour MS, Ibrahium AT, El‐Sherif AA, Mahmoud WH. transpeptidases. Eur J Med Chem. 2020;194:112262.
Organotin(IV) complexes: Synthesis, characterization, DFT,
and molecular docking studies unveiling their potential doi: 10.1016/j.ejmech.2020.112262
biomedical uses. Appl Organomet Chem. 2024;38(11):e7656. 30. Lima LM, Da Silva BN, Barbosa G, Barreiro EJ. β-lactam
antibiotics: An overview from a medicinal chemistry
doi: 10.1002/aoc.7656
perspective. Eur J Med Chem. 2020;208:112829.
19. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking:
A powerful approach for structure-based drug discovery. doi: 10.1016/j.ejmech.2020.112829
Curr Comput Aided Drug Des. 2011;7(2):146-157. 31. Griffith EC, Wallace MJ, Wu Y, et al. The structural and

Volume 2 Issue 3 (2025) 81 doi: 10.36922/IMO025140019